logo-loader

ANGLE’s Parsortix to be in focus at AACC annual meeting

Last updated: 13:29 02 Aug 2016 BST, First published: 08:29 02 Aug 2016 BST

blood vials
Parsortix can capture cancer cells in blood for analysis.

ANGLE PLC’s (OTCMKTS:ANPCY, LON:AGL) Parsortix device will be the focus of a poster presentation at the American Association for Clinical Chemistry (AACC) annual meeting later today.

Posters are used at large conventions such as the AACC to showcase discoveries or developments.

In the case of ANGLE it will be used to demonstrate Parsortix’s ability to harvest breast cancer cells for subsequent gene expression analysis.

The presentation is based around the pioneering work of James Reuben, a professor at the University of Texas MD Anderson Cancer Center.

According to ANGLE chief technology officer, Shane Booth, gene expression analysis could prove a “very important” new diagnostic tool.

ANGLE PLC present at the Proactive One2One Investor Conference - January 11th

In a comprehensive presentation at the Proactive One2One Investor Conference, ANGLE PLC (AIM:AGL, OTCQX:ANPCY) CEO, Andrew Newland, and CFO, Ian Griffiths, detailed the company's innovative approach to cancer diagnosis and treatment. Newland emphasised ANGLE's breakthrough technology, the...

on 17/1/24